Synaptogenix Inc (SNPX)

[Biostudent]

Alzheimer’s twice as prevalent as thought.
Dr Cliff Jack, the Alexander Family Professor of Alzheimer's Disease Research at The Mayo Clinic, said: “The prevalence of Alzhiemer’s Disease are all based on clinical assessment. They’re just based on the question ‘do you have dementia?’

“But as a general rule the prevalence of amyloid and tau as denoted by biomarkers is about two times higher than the prevalence classically defined Alzheimer’s disease.

The market is bigger than thought.